STOCK TITAN

Nexalin Technology (NXL) investors approve reverse split authority while rejecting preferred stock

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Nexalin Technology, Inc. held its annual stockholder meeting on August 11, 2026. Of 22,011,302 common shares outstanding as of July 6, 2026, 13,912,110 shares, or about 63.2%, were present, establishing a quorum. Stockholders elected five directors and approved the 2026 Equity Incentive Plan. They also approved amendments authorizing the board, in its discretion, to implement one or more reverse stock splits of the common stock, with ratios ranging from 1-for-2 to 1-for-100 and in the aggregate not more than 1-for-250. An amendment to authorize 10 million shares of preferred stock and an amendment to provide for Officer Exculpation did not receive sufficient support. Stockholders ratified the appointment of CBIZ CPAS P.C. as independent registered public accounting firm for the year ending December 31, 2026.

Positive

  • Reverse stock split flexibility approved: Stockholders authorized one or more reverse stock splits between 1-for-2 and 1-for-100, in the aggregate not more than 1-for-250, giving the board structural capital flexibility.
  • Equity plan and auditor ratified: The 2026 Equity Incentive Plan and the appointment of CBIZ CPAS P.C. as independent registered public accounting firm for 2026 both received stockholder approval.

Negative

  • Preferred stock authorization rejected: Stockholders did not approve creating 10 million shares of preferred stock, limiting the company’s ability to use preferred equity for financing or structural purposes.
  • Officer exculpation amendment failed: Stockholders did not approve adding Officer Exculpation to the charter, leaving officers without the additional limitation on personal monetary liability that had been proposed.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Shares outstanding 22,011,302 shares Common stock outstanding as of July 6, 2026 record date
Shares represented 13,912,110 shares Shares present or by proxy at the August 11, 2026 annual meeting, about 63.2%
Reverse split approval votes For 12,458,652 Votes For amendments permitting reverse stock splits between 1-for-2 and 1-for-100, aggregate not more than 1-for-250
Equity plan approval votes For 8,248,630 Votes For the 2026 Equity Incentive Plan
Preferred stock authorization votes For 7,863,517 Votes For authorizing 10 million shares of preferred stock, proposal not approved
Auditor ratification votes For 13,362,297 Votes For ratifying CBIZ CPAS P.C. as independent registered public accounting firm for 2026
reverse stock split financial
"to effect one or more reverse stock splits of the Company’s Common Stock"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
broker non-votes financial
"Leslie Bernhard | 8,705,295 | 432,207 | 4,774,608"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
Equity Incentive Plan financial
"Approval of the Company’s 2026 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Officer Exculpation regulatory
"to provide for Officer Exculpation"
A charter clause that limits company officers’ personal responsibility for money damages when they make business decisions that turn out poorly, unless they acted in bad faith, engaged in intentional wrongdoing, or took improper personal gain. It matters to investors because it changes the practical risk and accountability for senior managers—similar to giving a driver limited crash liability, it can encourage bold decision-making but may reduce the chance shareholders can recover losses if officers behaved improperly.
independent registered public accounting firm financial
"as the Company’s independent registered public accounting firm for the year ending"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What was the quorum and turnout at Nexalin Technology (NXL) 2026 annual meeting?

The quorum was met with 13,912,110 shares present or represented by proxy out of 22,011,302 shares outstanding as of July 6, 2026, representing approximately 63.2% of the common stock entitled to vote.

Which director nominees were elected at Nexalin Technology (NXL) on August 11, 2026?

Stockholders elected Leslie Bernhard, Mark White, David Owens, M.D., Alan Kazden, and Ben V. Hu, M.D.. Each received more votes For than Withheld, with additional broker non-votes reported.

Did Nexalin Technology (NXL) stockholders approve a reverse stock split authority?

Yes. Stockholders approved amendments permitting one or more reverse stock splits at ratios from 1-for-2 to 1-for-100, and in the aggregate not more than 1-for-250, at the board’s discretion.

Was Nexalin Technology’s (NXL) 2026 Equity Incentive Plan approved?

Yes. The 2026 Equity Incentive Plan received 8,248,630 votes For, 815,467 Against, and 73,405 Abstain, with 4,774,608 broker non-votes, resulting in stockholder approval of the plan.

Did Nexalin Technology (NXL) stockholders authorize 10 million preferred shares?

No. The proposal to authorize 10 million shares of preferred stock received 7,863,517 For, 1,208,690 Against, and 65,295 Abstain, plus 4,774,608 broker non-votes, and was not approved.

Who is Nexalin Technology’s (NXL) independent auditor for 2026?

Stockholders ratified CBIZ CPAS P.C. as the independent registered public accounting firm for the year ending December 31, 2026, with 13,362,297 votes For, 430,308 Against, and 119,505 Abstain.
false 0001527352 0001527352 2026-08-11 2026-08-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): August 11, 2026

 

NEXALIN TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41507   27-5566468
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

1776 Yorktown Street, Suite 550
Houston
, TX 77056

Registrant’s telephone number, including area code: (832) 260-0222

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   NXL   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

   

 

 

Item 5.07Submission of Maters to a Vote of Security Holders.

 

The annual meeting (the “Annual Meeting”) of the stockholders of Nexalin Technology, Inc. (the “Company”) was convened at 10:00 a.m. Eastern time on August 11, 2026. Of the 22,011,302 shares of the Company’s common stock, par value $0.001 per share (the “common stock”), outstanding at the close of business on July 6, 2026, the record date for the Annual Meeting, 13,912,110 shares of common stock were present or represented by proxy at the Annual Meeting, which amounts to approximately 63.2% of the shares of the Company’s common stock outstanding and entitled to vote. As a result, quorum was met. At the Annual Meeting, the Company’s stockholders voted on the six proposals described below. The results of the items voted on at the Annual Meeting are as follows.

 

Item One: Election of five directors of the Company:

 

Name For Withheld Broker Non-Votes
Leslie Bernhard 8,705,295 432,207 4,774,608
Mark White 8,840,686 296,816 4,774,608
David Owens, M.D. 8,785,477 352,025 4,774,608
Alan Kazden 8,790,402 347,100 4,774,608
Ben V. Hu, M.D. 8,763,598 373,904 4,774,608

 

Item Two: Approval of the Company’s 2026 Equity Incentive Plan:

 

For Against Abstain Broker Non-Votes
8,248,630 815,467 73,405 4,774,608

 

Item Three: Approval of one or more amendments of the Company’s Second Amended and Restated Certificate of Incorporation to effect one or more reverse stock splits of the Company’s Common Stock, at a ratio ranging from any whole number between and including 1-for-2 and 1-for-100 and in the aggregate not more than 1-for-250, inclusive, as determined by the Company’s board of directors in its discretion, subject to the authority of the board of directors to abandon such amendments:

 

For Against Abstain
12,458,652 1,401,464 51,994

 

Item Four: Approval and adoption of an Amendment to the Amended and Restated Certificate of Incorporation of the Company to authorize 10 million shares of preferred stock:

 

For Against Abstain Broker Non-Votes
7,863,517 1,208,690 65,295 4,774,608

 

Item Five: Approval and adoption of an Amendment to the Amended and Restated Certificate of Incorporation of the Company to provide for Officer Exculpation:

 

For Against Abstain Broker Non-Votes
8,239,359 772,759 125,384 4,774,608

 

Item Six: Ratification of the appointment of CBIZ CPAS P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026:

 

For Against Abstain
13,362,297 430,308 119,505

 

Based on the foregoing votes, the director nominees listed in Item 1 were elected, and Items 2, 3, and 6 were approved. Items 4 and 5 were not approved. No other items were presented for stockholder approval at the Annual Meeting.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report on form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NEXALIN TECHNOLOGY, INC.
     
  By: /s/ Mark White
    Mark White
    Chief Executive Officer
     
Dated: August 11, 2026    

 

2

Filing Exhibits & Attachments

3 documents